BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 20013612)

  • 1. Thyroid Papillary Microcarcinoma: Etiology, Clinical Manifestations,Diagnosis, Follow-up, Histopathology and Prognosis.
    Dideban S; Abdollahi A; Meysamie A; Sedghi S; Shahriari M
    Iran J Pathol; 2016; 11(1):1-19. PubMed ID: 26870138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papillary microcarcinoma of the thyroid.
    Shaha AR; Tuttle RM; Shah JP
    J Surg Oncol; 2007 Jun; 95(7):532-3. PubMed ID: 17192917
    [No Abstract]   [Full Text] [Related]  

  • 3. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
    Vassilopoulou-Sellin R; Schultz PN; Haynie TP
    Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thyroid papillary microcarcinoma. Salah Azaiz Institute experience].
    Oueslati Z; Aloui M; Gritli S; Touati S; el-May A; Gamoudi A; Ben-Slimene F; Ladgham A
    Rev Laryngol Otol Rhinol (Bord); 2002; 123(1):39-42. PubMed ID: 12200999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas ligand (FasL, Apo-1L/CD95L) expression and clinical outcome in papillary microcarcinoma and papillary thyroid carcinomas with diameter smaller than 1.5 centimeters.
    Bayraktaroglu T; Boztepe H; Kapran Y; Tanakol R; Alagöl F
    Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):537-43. PubMed ID: 20013612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current perspectives on papillary carcinoma of the thyroid gland.
    Chiu MK; Sherry RM; Wei JP
    J Med Assoc Ga; 1992 Aug; 81(8):442-4. PubMed ID: 1512532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodine therapy for papillary and follicular thyroid carcinoma.
    Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thyroid microcarcinoma].
    Lantsov DS
    Arkh Patol; 2006; 68(4):54-7. PubMed ID: 16986502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prospective therapy study in differentiated thyroid carcinoma].
    Gemsenjäger E; Heitz P; Martina B
    Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choroidal and skin metastases from papillary thyroid cancer: case and a review of the literature.
    Avram AM; Gielczyk R; Su L; Vine AK; Sisson JC
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5303-7. PubMed ID: 15531474
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.